NOVEL NEW ENZYME AND PRODUCT FROM ENCYSTING GIARDIA
来自包囊贾第鞭毛虫的新型酶和产品
基本信息
- 批准号:2077285
- 负责人:
- 金额:$ 11.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-15 至 2000-08-14
- 项目状态:已结题
- 来源:
- 关键词:Giardia N acetylgalactosamine SDS polyacrylamide gel electrophoresis antiprotozoal agents biological products cell differentiation chemical structure function drug design /synthesis /production enzyme activity enzyme biosynthesis enzyme inhibitors enzyme substrate gel filtration chromatography giardiasis high performance liquid chromatography microorganism culture paper chromatography parasitic disease chemotherapy parasitism polysaccharides protozoal cyst thin layer chromatography ultracentrifugation uridine diphosphate
项目摘要
Giardia duodenalis (syn. G. lamblia, G. intestinalis) is a pathogenic
protozoan parasite, and in the United States and abroad, is a leading
cause of intestinal disease in waterborne outbreaks, nursery or day-care
facilities, and homosexuals. Fecal-oral transmission of the disease
occurs when viable cysts are ingested, and excystation occurs in the
upper small intestine with the emergence of two trophozoites.
Trophozoites colonize the small intestine where, at least in part
stimulated by bile, they form new cysts (encystment) which are shed in
the feces. During encystment, Giardia trophozoites synthesize a
filamentous cyst wall which is composed, in large part, of the amino
sugar, N-acetylgalactosamine (GalNAc) which is undetectable in
non-encysting trophozoites. In order to accomplish this, Giardia
trophozoites use a synthetic pathway of inducible enzymes to convert
endogenous glucose to GalNAc. This pathway is not only paramount in their
cytodifferentiation from trophozoite to cyst, but represents a potential
point of chemotherapeutic attack against Giardia. Several drugs are
currently being used to treat giardiasis and many have unpleasant side
effects. Some, including the most frequently used drug, metronidazole,
are at risk of becoming obsolete. While resistance to metronidazole has
not yet become a problem in practice, in vivo and in vitro resistance has
been demonstrated and thus a potential problem exists.
Since we have only recently discovered the inducible GalNAc synthetic
pathway in Giardia, little is known of the regulation or genetic control
of the enzymes that comprise it. Indeed, since discovery of this pathway,
we have also found a previously undescribed enzyme activity, tentatively
referred to as "cyst wall synthetase". "Cyst wall synthetase" activity
appears to fix GalNAc into the insoluble filaments that compose the outer
cyst wall of Giardia. It is our intent in this proposal to continue
studying this pathway by 1) purifying, characterizing and localizing the
inducible, particulate "cyst wall synthetase" and 2) determining the
chemical nature of its uncharacterized product which is likely to be a
major component of the Giardia cyst wall. We will employ enzyme and
protein purification techniques to achieve the enzymatic aim and standard
methods of carbohydrate analyses to achieve the chemical analysis of the
enzyme's product. Since there is a paucity of information of the
mechanisms of encystment in most protozoa, the detailed information
generated here will provide important information about a key metabolic
pathway vital to Giardia encystment and transmission (and perhaps related
to that in other cyst~producing protozoa), and will likely provide us
with information important to improving chemotherapy in the future.
十二指肠贾第鞭毛虫(同蓝氏贾第鞭毛虫,肠贾第鞭毛虫)是一种致病性的鞭毛虫
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Metabolic changes in Giardia intestinalis during differentiation
- DOI:10.2307/3284474
- 发表时间:1998-04-01
- 期刊:
- 影响因子:1.3
- 作者:Paget, TA;Macechko, PT;Jarroll, EL
- 通讯作者:Jarroll, EL
Purification and characterization of UDP-N-acetylglucosamine pyrophosphorylase from encysting Giardia.
来自包囊贾第鞭毛虫的 UDP-N-乙酰氨基葡萄糖焦磷酸化酶的纯化和表征。
- DOI:10.1016/s0166-6851(98)00076-0
- 发表时间:1998
- 期刊:
- 影响因子:1.5
- 作者:Bulik,DA;Lindmark,DG;Jarroll,EL
- 通讯作者:Jarroll,EL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD L JARROLL其他文献
EDWARD L JARROLL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD L JARROLL', 18)}}的其他基金
GIARDIA ENCYSTMENT: CONTROL OF GA1NAC SYNTHESIS
贾第鞭毛虫包囊:GA1NAC 合成的控制
- 批准号:
6157624 - 财政年份:2000
- 资助金额:
$ 11.58万 - 项目类别:
SYNTHESIS OF N-ACETYLGALACTOSAMINE IN ENCYSTING GIARDIA
包囊贾第鞭毛虫中 N-乙酰半乳糖胺的合成
- 批准号:
3436813 - 财政年份:1991
- 资助金额:
$ 11.58万 - 项目类别:
相似海外基金
Impact of N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on the Progression of Melanoma
N-乙酰半乳糖胺-4-硫酸酯酶(芳基硫酸酯酶 B)对黑色素瘤进展的影响
- 批准号:
10399551 - 财政年份:2021
- 资助金额:
$ 11.58万 - 项目类别:
Impact of N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on the Progression of Melanoma
N-乙酰半乳糖胺-4-硫酸酯酶(芳基硫酸酯酶 B)对黑色素瘤进展的影响
- 批准号:
10664841 - 财政年份:2021
- 资助金额:
$ 11.58万 - 项目类别:
Impact of N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on the Progression of Melanoma
N-乙酰半乳糖胺-4-硫酸酯酶(芳基硫酸酯酶 B)对黑色素瘤进展的影响
- 批准号:
10258903 - 财政年份:2021
- 资助金额:
$ 11.58万 - 项目类别:
Novel Dried Blood Spot Mass Spectrometry Functional Assays for Lysosomal Acid Lipase and N-acetylgalactosamine-sulfate Sulfatases for Use in Newborn Screening
用于新生儿筛查的溶酶体酸性脂肪酶和 N-乙酰半乳糖胺硫酸酯硫酸酯酶的新型干血斑质谱功能分析
- 批准号:
9238498 - 财政年份:2015
- 资助金额:
$ 11.58万 - 项目类别:
SYNTHESIS OF N-ACETYLGALACTOSAMINE IN ENCYSTING GIARDIA
包囊贾第鞭毛虫中 N-乙酰半乳糖胺的合成
- 批准号:
3436813 - 财政年份:1991
- 资助金额:
$ 11.58万 - 项目类别: